Wave Biotech, LLC, has announced that MacroGenics has installed 200-liter Wave Bioreactors ® for its new facility. The Wave Bioreactors ® will enable MacroGenics - which is focused on the development, ...

Over the past decade, disposable technologies have become a reality in biotech processes. The use of disposables in research and manufacturing allows high flexibility. Over the past decade, disposable ...

Lentigen Corporation and Wave Biotech Announce Formation of Collaboration BALTIMORE and SOMERSET, N.J., January 25, 2007 -- Lentigen Corporation and Wave Biotech, LLC announced today that they have ...

An updated bioreactor based on rocking technology has more advanced controls but is easier for biopharmaceutical manufacturers to use. Single-use bioreactors come in all shapes and sizes that fit the ...

Mammalian cells are most commonly used for the production of biopharmaceuticals. Over the past 25 years the focus has mainly been on protein-based therapeutic hormones, enzymes, antibodies, and ...

GOETTINGEN, Germany, Oct 31, 2008 (BUSINESS WIRE) -- Sartorius Stedim Biotech GmbH (SSB) (Paris:DIM), a group subsidiary of the biotechnology supplier Sartorius Stedim Biotech, signed an agreement to ...

After using its "disposable" manufacturing technology to make cell-based drugs for contract clients at its facility in Marlborough, Xcellerex Inc. has closed a $20 million Series B round to begin ...

The need for γ-retroviral (gRV) vectors with a self-inactivating (SIN) design for clinical application has prompted a shift in methodology of vector manufacturing from the traditional use of stable ...